Party at BIO conference that featured topless dancers draws fire from organization
One attendee called the PABNAB party entertainment "tone-deaf," but it's not the first event of its kind at a biotech show.
Gates Foundation debuts nonprofit biotech firm at BIO
The Gates Medical Research Institute will develop products for malaria, tuberculosis, enteric and diarrheal diseases.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
CAR-T has a lot of promise, but some big challenges remain, experts at BIO, ASCO say
Many issues around CAR-T remain to be hashed out, but many experts pointed to infrastructure and clinics' capabilities as crucial.
Janssen sees a potential myeloma CAR-T edge, exec says at BIO
The company plans to open its upcoming trial of a Chinese-developed CAR-T at four initial sites later this year.
Gottlieb at BIO: FDA developing processes around right-to-try law
FDA commissioner gives clues of agency's right-to-try strategy in Q&A session during chat with BIO President Jim Greenwood.
Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies
CAR-Ts have generated excitement, but bispecific monoclonal antibodies may continue to have a competitive edge in some cases.
presented by
The Top 5 Home Care Franchise Opportunities in the U.S.
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.